Lindahl assisted Newbury Pharmaceuticals AB with listing
Lindahl assisted Newbury Pharmaceuticals AB with listing of the company's shares on Nasdaq First North Growth Market.
In connection with the listing, a new share issue of approximately SEK 50 million was carried out for the general public in Sweden, Norway, Denmark and Finland as well as for institutional investors. There was a great deal of interest in the offer, which was oversubscribed. The first day of trading is 4 February.
Lindahl acted as legal advisor to Newbury in connection with the listing and raising capital and the team consisted mainly of Johan Herrström and Pontus Söderberg.
About our client Newbury
Newbury provides prescription medicines to patients and healthcare providers in the Scandinavian market. The company focuses on speciality medicines and proprietary brands with particular focus on oncology, rare diseases and neurology.
Do you want to know more? Contact:
Johan Herrström
Managing Partner Malmö | AdvokatPontus Söderberg
Senior Associate | AdvokatCarousel items
-
Cases and transactions
5/6/2026
Lindahl advises Equistone Partners Europe on the sale of BUKO Group
Lindahl, together with Clifford Chance, advises Equistone Partners Europe on the sale of BUKO Group to Groupe Bruxelles Lambert.
-
Knowledge
5/6/2026
A reformed environmental law – what you need to know
Swedish environmental law is undergoing a historic reform. Learn what the new Environmental Permit Authority, revised review tracks and shorter appeal chains mean for your operations – and what you need to do now.
-
News articles
5/4/2026
Johan Norderyd named Practitioner of the Year at the Managing IP Awards
Johan Norderyd has been named the winner in the Sweden Practitioner of the Year (Law Firms) category at the Managing IP EMEA Awards 2026.
-
Portraits
1/20/2026
How I use AI in my daily work as a lawyer
AI is no longer the future – it is everyday reality. Johanna Karlsson, lawyer and senior associate at Lindahl, talks about how AI tools such as Legora have become a natural part of her workflow.
-
Read more news and insights?
